Research Topic · Peer-Reviewed

Polymyxins

Polymyxins are a class of antibiotics derived from bacteria which are used to treat a variety of infections caused by Gram-negative bacteria. These antibiotics work by disrupting the outer membrane of bacterial cells and by interfering with the production of toxins. Polymyxins have been used to treat a variety of in…

📚 0 peer-reviewed articles cited 🗓 Reviewed June 2026

Overview

Polymyxins are a class of antibiotics derived from bacteria which are used to treat a variety of infections caused by Gram-negative bacteria. These antibiotics work by disrupting the outer membrane of bacterial cells and by interfering with the production of toxins. Polymyxins have been used to treat a variety of infections, such as pneumonia, sepsis and urinary tract infections, among others. In addition, they have found wide use in the treatment of antibiotic-resistant infections, especially in hospitalized patients. They have also been used to treat drug-resistant Staphylococcus aureus (MRSA) infections, as well as infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii. Polymyxins are considered a last-resort treatment, as they can damage the kidneys and can cause significant nephrotoxicity. They should be used sparingly and only in cases where no other antibiotics are effective.

Research published in this journal

No peer-reviewed research on this exact topic has been published in International Journal of Cell yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in International Journal of Cell.

Journal editorial board
Faiz Ul Amin · Korea, Democratic People's Rep Yuping Li · United States Hong WAN · United Kingdom

This page summarises published research for orientation; it is not medical or professional advice.